1. Home
  2. AFMD vs AIEV Comparison

AFMD vs AIEV Comparison

Compare AFMD & AIEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • AIEV
  • Stock Information
  • Founded
  • AFMD 2000
  • AIEV 2011
  • Country
  • AFMD Germany
  • AIEV United States
  • Employees
  • AFMD N/A
  • AIEV N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • AIEV Blank Checks
  • Sector
  • AFMD Health Care
  • AIEV Finance
  • Exchange
  • AFMD Nasdaq
  • AIEV Nasdaq
  • Market Cap
  • AFMD 17.5M
  • AIEV 19.3M
  • IPO Year
  • AFMD 2014
  • AIEV N/A
  • Fundamental
  • Price
  • AFMD $1.15
  • AIEV $0.30
  • Analyst Decision
  • AFMD Strong Buy
  • AIEV
  • Analyst Count
  • AFMD 5
  • AIEV 0
  • Target Price
  • AFMD $13.50
  • AIEV N/A
  • AVG Volume (30 Days)
  • AFMD 363.4K
  • AIEV 1.3M
  • Earning Date
  • AFMD 11-14-2024
  • AIEV 02-15-2025
  • Dividend Yield
  • AFMD N/A
  • AIEV N/A
  • EPS Growth
  • AFMD N/A
  • AIEV N/A
  • EPS
  • AFMD N/A
  • AIEV N/A
  • Revenue
  • AFMD $6,287,085.00
  • AIEV N/A
  • Revenue This Year
  • AFMD N/A
  • AIEV N/A
  • Revenue Next Year
  • AFMD $212.48
  • AIEV N/A
  • P/E Ratio
  • AFMD N/A
  • AIEV N/A
  • Revenue Growth
  • AFMD N/A
  • AIEV N/A
  • 52 Week Low
  • AFMD $1.03
  • AIEV $0.22
  • 52 Week High
  • AFMD $8.95
  • AIEV $12.12
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 28.57
  • AIEV N/A
  • Support Level
  • AFMD $1.03
  • AIEV N/A
  • Resistance Level
  • AFMD $1.41
  • AIEV N/A
  • Average True Range (ATR)
  • AFMD 0.11
  • AIEV 0.00
  • MACD
  • AFMD 0.05
  • AIEV 0.00
  • Stochastic Oscillator
  • AFMD 23.53
  • AIEV 0.00

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About AIEV Thunder Power Holdings Inc. Common Stock

Thunder Power Holdings Inc is engaged in the design and development of high-performance electric vehicles.

Share on Social Networks: